David M. Knott Jr’s Travere Therapeutics TVTX Stock Holding History

David M. Knott Jr’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.18M	Sell	140,633 -45,367	-24%	-$1.36M	2.49%	12
2025 Q4	$7.11M	Sell	186,000 -74,000	-28%	-$2.41M	3.29%	6
2025 Q3	$6.21M	Hold	260,000	–	–	2.51%	9
2025 Q2	$3.85M	Buy	260,000 +32,000	+14%	+$530K	1.74%	10
2025 Q1	$4.09M	Hold	228,000	–	–	1.93%	11
2024 Q4	$3.97M	Sell	228,000 -30,231	-12%	-$535K	1.44%	12
2024 Q3	$3.61M	Sell	258,231 -7,735	-3%	-$80.6K	1.27%	19
2024 Q2	$2.19M	Buy	265,966 +35,000	+15%	+$236K	0.87%	25
2024 Q1	$1.78M	Buy	230,966 +9,961	+5%	+$84K	0.63%	31
2023 Q4	$1.99M	Buy	221,005 +120,688	+120%	+$879K	0.76%	23
2023 Q3	$897K	Buy	+100,317	New	+$1.42M	0.34%	40

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

David M. Knott Jr's TVTX Position: Q1 2026 in Review

David M. Knott Jr reduced its Travere Therapeutics (TVTX) stake by 24% in Q1 2026, selling an estimated $1.36M and leaving 140,633 shares worth $4.18M. The position accounts for 2.49% of the portfolio, ranked #12.

David M. Knott Jr first reported a position in TVTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.11M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

David M. Knott Jr held 140,633 shares of Travere Therapeutics worth $4.18M as of Q1 2026.
David M. Knott Jr sold 45,367 Travere Therapeutics shares in Q1 2026, an estimated $1.36M.
Travere Therapeutics made up 2.49% of David M. Knott Jr's portfolio in Q1 2026, its #12 holding.
David M. Knott Jr first reported a position in Travere Therapeutics in Q3 2023 and has held it in 11 quarters since.
David M. Knott Jr's Travere Therapeutics position peaked at $7.11M in Q4 2025.
260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.